AlzeCure Pharma AB
Share:
Subscribe:

Martin Jönsson, VD

Wed, Nov 11, 2020 10:00 CET

Martin Jönsson, VD

Medium resolution

Original resolution

Subscribe

Related Releases

AlzeCure publishes its interim report for January – September 2020 Tue, Nov 17, 2020 08:00 CET

AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease Thu, Nov 12, 2020 12:15 CET

Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website Wed, Nov 11, 2020 10:00 CET